Combination of Multiple Molecular Markers Can Improve Prognostication in Patients With Locally Advanced and Lymph Node Positive Bladder Cancer

作者: Shahrokh F. Shariat , Daher C. Chade , Pierre I. Karakiewicz , Raheela Ashfaq , Hendrik Isbarn

DOI: 10.1016/J.JURO.2009.08.115

关键词:

摘要: Purpose: We tested whether the combination of 4 established cell cycle regulators (p53, pRB, p21 and p27) could improve ability to predict clinical outcomes in a large multi-institutional collaboration patients with pT3-4N0 or pTany Npositive urothelial carcinoma bladder. also assessed molecular markers is superior any individual biomarker.Materials Methods: The study comprised 692 bladder treated radical cystectomy bilateral lymphadenectomy (median followup 5.3 years). Scoring was performed using advanced imaging color detection software. base model incorporated patient age, gender, stage, grade, lymphovascular invasion, number lymph nodes removed, positive nodes, concomitant situ adjuvant chemotherapy.Results: Individual did not predictive accuracy for disease recurrence cancer specific mortalit...

参考文章(30)
M. Antelo, J. L. Palmer, C. P. N. Dinney, W. F. Benedict, S.-X. Hu, M. Liebert, H. B. Grossman, p53 and RB expression predict progression in T1 bladder cancer. Clinical Cancer Research. ,vol. 4, pp. 829- 834 ,(1998)
Susan Groshen, Richard J. Cote, John P. Stein, Hong Ji Xu, Clive R. Taylor, Donald G. Skinner, Sunanda J. Chatterjee, Matthew D. Dunn, William F. Benedict, Quoc Chau Tran, Shi Xue Hu, Shan Rong Shi, Elevated and Absent pRb Expression Is Associated with Bladder Cancer Progression and Has Cooperative Effects with p53 Cancer Research. ,vol. 58, pp. 1090- 1094 ,(1998)
PATRICIA M. GRAMBSCH, TERRY M. THERNEAU, Proportional hazards tests and diagnostics based on weighted residuals Biometrika. ,vol. 81, pp. 515- 526 ,(1994) , 10.1093/BIOMET/81.3.515
C. Cordon-Cardo, D. Wartinger, D. Petrylak, G. Dalbagni, W. R. Fair, Z. Fuks, V. E. Reuter, Altered Expression of the Retinoblastoma Gene Product: Prognostic Indicator in Bladder Cancer Journal of the National Cancer Institute. ,vol. 84, pp. 1251- 1256 ,(1992) , 10.1093/JNCI/84.16.1251
William F Benedict, Seth P Lerner, Jain Zhou, Xiaohua Shen, Hideo Tokunaga, Bogdan Czerniak, Level of retinoblastoma protein expression correlates with p16 (MTS-1/INK4A/CDKN2) status in bladder cancer Oncogene. ,vol. 18, pp. 1197- 1203 ,(1999) , 10.1038/SJ.ONC.1202452
Stephan Madersbacher, Werner Hochreiter, Fiona Burkhard, George N. Thalmann, Hansjörg Danuser, Regula Markwalder, Urs E. Studer, Radical Cystectomy for Bladder Cancer Today--A Homogeneous Series Without Neoadjuvant Therapy Journal of Clinical Oncology. ,vol. 21, pp. 690- 696 ,(2003) , 10.1200/JCO.2003.05.101
Richard J. Cote, David Esrig, Susan Groshen, Peter A. Jones, Donald G. Skinner, p53 and treatment of bladder cancer Nature. ,vol. 385, pp. 123- 124 ,(1997) , 10.1038/385123B0
Shahrokh F. Shariat, Ganesh S. Palapattu, Pierre I. Karakiewicz, Craig G. Rogers, Amnon Vazina, Patrick J. Bastian, Mark P. Schoenberg, Seth P. Lerner, Arthur I. Sagalowsky, Yair Lotan, Discrepancy between Clinical and Pathologic Stage: Impact on Prognosis after Radical Cystectomy European Urology. ,vol. 51, pp. 137- 151 ,(2007) , 10.1016/J.EURURO.2006.05.021
A. Jemal, R. Siegel, E. Ward, Y. Hao, J. Xu, T. Murray, M. J. Thun, Cancer statistics, 2008. CA: A Cancer Journal for Clinicians. ,vol. 58, pp. 71- 96 ,(2008) , 10.3322/CA.2007.0010